Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 26:2020:6315718.
doi: 10.1155/2020/6315718. eCollection 2020.

Evaluation of Four Rapid Tests for Detection of Hepatitis B Surface Antigen in Ivory Coast

Bamory Dembele  1   2 , Roseline Affi-Aboli  2   3 , Mathieu Kabran  2   3 , Daouda Sevede  4 , Vanessa Goha  2 , Aimé Cézaire Adiko  1   2 , Rodrigue Kouamé  2 , Emile Allah-Kouadio  5 , Andre Inwoley  2   3
Affiliations

Evaluation of Four Rapid Tests for Detection of Hepatitis B Surface Antigen in Ivory Coast

Bamory Dembele et al. J Immunol Res. .

Abstract

Background: Hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide. Hepatitis B surface antigen (HBsAg) rapid diagnostic tests (RDTs) could be an ideal tool for a large-scale HBV screening in settings with high endemicity but limited infrastructure. The aim of this study was to evaluate the diagnosis performance of such RDTs for screening HBV infection in Ivory Coast.

Methods: From September 2018 to January 2019, a cross-sectional phase I evaluation study of RDTs was conducted in three laboratories of Abidjan (CeDReS, CNTS and IPCI), on a panel of 405 whole blood samples and 699 plasmas. Four HBsAg RDTs (Determine™ HBsAg, SD Bioline HBsAg WB®, Standard Q HBsAg® and Vikia HBsAg®) were evaluated. The diagnostic performance (sensitivity and specificity) was calculated in comparison to the reference sequential algorithms of two EIA tests (Dia.Pro HBsAg® one version ULTRA and Monolisa™ HBsAg ULTRA).

Results: The Determine™ HBsAg and Vikia HBsAg® tests performed well, with 100% of sensitivity, specificity both on plasma and on whole blood. For SD Bioline HBsAg WB® and Standard Q HBsAg®, the specificities were 99.8% and the sensitivities 99.3% and 97.1% respectively. Finally, there were a total of 19 false negative results: 3 with SD Bioline HBsAg WB® and 16 with Standard Q HBsAg®.

Conclusion: Determine HBsAg® from Alere and Vikia HBsAg® from Biomérieux are the most suitable RDTs for screening for HBV in Ivory Coast. A phase II evaluation must be initiated.

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. World Health Organization. Global hepatitis report, 2017. 2017 December 2019, http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?....
    1. Schweitzer A., Horn J., Mikolajczyk R. T., Krause G., Ott J. J. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. The Lancet. 2015;386(10003):1546–1555. doi: 10.1016/S0140-6736(15)61412-X. - DOI - PubMed
    1. Lohouès-Kouacou M.-J., Assi C., Simen-Kapeu A., et al. Prevalence of HBV Sero-markers in two Different Socioeconomic Groups of Schoolchildren from Abidjan, Côte d’ Ivoire. Journal of Gastroenterology and Hepatology Research. 2013;2(9):798–802.
    1. Assi C., Ouattara A., Kone S., et al. Screening for Hepatitis B and C in Occupational Settings: Cross-Sectional Study about 4268 Corporates Agents in Côte d’Ivoire. Open Journal of Gastroenterology. 2017;7(3):89–95. doi: 10.4236/ojgas.2017.73010. - DOI
    1. Seri B., Minga A., Gabillard D., et al. Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in Côte d’Ivoire. Open Forum Infectious Diseases. 2018;5(4, article ofy060) doi: 10.1093/ofid/ofy060. - DOI - PMC - PubMed

Publication types

Substances